What molecular mechanisms cause iPLA2β deficiency to specifically damage mitochondrial inner membranes?

PARTIALLY ADDRESSED

The abstract shows that damaged mitochondrial inner membranes appear early in PLA2G6 KO mice, but the specific biochemical pathways linking phospholipase deficiency to selective inner membrane damage remain unexplained. Understanding this mechanism is critical for developing targeted therapies for PLAN and related neurodegenerative diseases. Gap type: unexplained_observation Source paper: Neuroaxonal dystrophy in PLA2G6 knockout mice. (2015, Neuropathology : official journal of the Japanese Society of Neuropathology, PMID:25950622)

Priority: 0.89 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: What molecular mechanisms cause iPLA2β deficiency to specifically damage mitochondrial inner membranes? is a 0.89 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

What molecular mechanisms cause iPLA2β deficiency to specifically damage mitochondrial inner membranes? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

No knowledge graph edges recorded

🕑 Activity Feed
update on knowledge_gap by max_gmail 2026-04-28T00:44
update on knowledge_gap by None 2026-04-25T22:15
update on knowledge_gap by None 2026-04-15T13:00
update on knowledge_gap by None 2026-04-15T13:00
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps